中部早熟性または早期正常性のある少女に対する薬剤療法の有効性および安全性:遡及的なコホート研究
Chunsong Yang1,2,3,4,5, Xi Huang6,7, Zheng Liu8,9,10,11,7
1Department of Pharmacy, West China Second University Hospital, Sichuan University, Chengdu, 610041, China. yangchunsong_123@126.com.
Scientific reports
|August 29, 2025
まとめ
ゴナドトロフィン放出ホルモンアナログ (GnRHa) と再結合ヒト成長ホルモン (rhGH) を併用した治療は,中央早熟性青春期 (CPP) と早期正常性青春期 (ENP) の女子における最終的な成人身長を改善した. しかし,このアプローチは有害事象を増加させ,リスクと利益の慎重な検討を必要とした.
科学分野:
- 小児内分泌学
- 生殖医学
- 薬理学について
背景:
- 中枢早熟性 (CPP) と早期正常性 (ENP) は,女の子の急速な性発育を伴うもので,治療はしばしば処方箋外である.
- これらの状態で再結合ヒト成長ホルモン (rhGH) の使用は,堅固な臨床証拠がない.
- ゴナドトロフィン放出ホルモン (GnRHa) アナログは一般的な治療法ですが,rhGHとの組み合わせはさらなる調査を必要とします.
研究 の 目的:
- 女児におけるCPPとENPの治療において,rhGHと併用したGnRHaの長期的な有効性と安全性を比較する.
- 介入の年齢が治療結果にどのように影響するかを調べる
- 最終的な成人の身長 (FAH) と身長増加を主な有効性測定値として評価する.
主な方法:
- 2013年1月から2018年12月までの間にCPPまたはENPと診断された182人の女性の医療データを遡及的に収集しました.
- 多変量線形回帰分析で,基線因数と臨床経験を調整する.
- 介入年齢と治療期間に基づいて有効性を評価するサブグループ分析.
主要な成果:
- 併用療法 (GnRHa + rhGH) は,GnRHa単独療法または治療なしと比較して,著しく高いFAH,身長増加,および遺伝的身長増加をもたらしました.
- 禁食インスリン値上昇と甲状腺機能低下などの有害事象の発生率が高かった.
- サブグループ分析では,10歳未満で治療を開始し,1年以上継続した患者に併用療法による利点が示され,特定のサブグループでは1年未満で治療されたFAHの有意な差異は認められなかった.
結論:
- GnRHaとrhGHの組み合わせ治療は,特に早期に開始され,長期にわたって継続された場合,CPPとENPの女の子の最終的な成人身長を改善することができます.
- 薬剤併用療法を開始する前に,効果,リスク,費用対効果を全面的に評価することが必要である.
- 個別的な治療決定は,潜在的身長増加と副作用のリスクの増加を考慮する必要があります.
関連する概念動画
Signs of Puberty
606
Puberty is a critical phase, typically beginning between the ages of 8 and 13 in girls and 9 and 14 in boys, though timing can vary based on genetics, environmental factors, and overall health. This period is characterized by the development of secondary sexual characteristics and the attainment of reproductive potential. Endocrine changes underpin puberty, with hormonal surges of Luteinizing Hormone (LH) and Follicle-Stimulating Hormone (FSH) instigated by Gonadotropin-Releasing Hormone (GnRH)...
606
Psychosis: Goals of Pharmacotherapy
209
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
209
Drug Therapy
96
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
96
Drug Administration and Therapy Phases: Overview
738
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
738
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
293
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
A study on guinea pigs examined the...
293
Factors Affecting Drug Response: Overview
2.4K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.4K


